177 related articles for article (PubMed ID: 31247245)
21. Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses.
Königer C; Wingert I; Marsmann M; Rösler C; Beck J; Nassal M
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4244-53. PubMed ID: 25201958
[TBL] [Abstract][Full Text] [Related]
22. HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA.
Yan Z; Zeng J; Yu Y; Xiang K; Hu H; Zhou X; Gu L; Wang L; Zhao J; Young JAT; Gao L
J Hepatol; 2017 Jun; 66(6):1149-1157. PubMed ID: 28213165
[TBL] [Abstract][Full Text] [Related]
23. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus nucleocapsid uncoating: biological consequences and regulation by cellular nucleases.
Hu J; Tang L; Cheng J; Zhou T; Li Y; Chang J; Zhao Q; Guo JT
Emerg Microbes Infect; 2021 Dec; 10(1):852-864. PubMed ID: 33870849
[TBL] [Abstract][Full Text] [Related]
25. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.
He W; Li LX; Liao QJ; Liu CL; Chen XL
World J Gastroenterol; 2011 Mar; 17(11):1507-14. PubMed ID: 21472112
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the molecular events of covalently closed circular DNA synthesis in de novo Hepatitis B virus infection of human hepatoma cells.
Dezhbord M; Lee S; Kim W; Seong BL; Ryu WS
Antiviral Res; 2019 Mar; 163():11-18. PubMed ID: 30639437
[TBL] [Abstract][Full Text] [Related]
27. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.
Nassal M
Gut; 2015 Dec; 64(12):1972-84. PubMed ID: 26048673
[TBL] [Abstract][Full Text] [Related]
28. A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis.
Wing PA; Davenne T; Wettengel J; Lai AG; Zhuang X; Chakraborty A; D'Arienzo V; Kramer C; Ko C; Harris JM; Schreiner S; Higgs M; Roessler S; Parish JL; Protzer U; Balfe P; Rehwinkel J; McKeating JA
Life Sci Alliance; 2019 Apr; 2(2):. PubMed ID: 30918010
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
Ko C; Chakraborty A; Chou WM; Hasreiter J; Wettengel JM; Stadler D; Bester R; Asen T; Zhang K; Wisskirchen K; McKeating JA; Ryu WS; Protzer U
J Hepatol; 2018 Dec; 69(6):1231-1241. PubMed ID: 30142426
[TBL] [Abstract][Full Text] [Related]
30. Hepadnavirus Genome Replication and Persistence.
Hu J; Seeger C
Cold Spring Harb Perspect Med; 2015 Jul; 5(7):a021386. PubMed ID: 26134841
[TBL] [Abstract][Full Text] [Related]
31. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
Nair S; Zlotnick A
J Virol; 2018 May; 92(10):. PubMed ID: 29491156
[TBL] [Abstract][Full Text] [Related]
32. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z
Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308
[TBL] [Abstract][Full Text] [Related]
33. Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors.
Ko C; Su J; Festag J; Bester R; Kosinska AD; Protzer U
Antiviral Res; 2021 Oct; 194():105140. PubMed ID: 34284057
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of Hepatitis B Virus cccDNA Formation.
Wei L; Ploss A
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452329
[TBL] [Abstract][Full Text] [Related]
35. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].
Yao YQ; Zhang DF; Luo Y; Zhang DZ; Huang AL; Wang B; Zhou WP; Ren H; Guo SH
Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B Virus Covalently Closed Circular DNA Formation in Immortalized Mouse Hepatocytes Associated with Nucleocapsid Destabilization.
Cui X; Guo JT; Hu J
J Virol; 2015 Sep; 89(17):9021-8. PubMed ID: 26085156
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of Hepatitis B Virus cccDNA and Minichromosome Formation and HBV Gene Transcription.
Gómez-Moreno A; Ploss A
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675950
[TBL] [Abstract][Full Text] [Related]
38. New Insights on Molecular Mechanism of Hepatitis B Virus Covalently Closed Circular DNA Formation.
Marchetti AL; Guo H
Cells; 2020 Nov; 9(11):. PubMed ID: 33172220
[TBL] [Abstract][Full Text] [Related]
39. An allosteric inhibitor of sirtuin 2 blocks hepatitis B virus covalently closed circular DNA establishment and its transcriptional activity.
Tang L; Remiszewski S; Snedeker A; Chiang LW; Shenk T
Antiviral Res; 2024 Jun; 226():105888. PubMed ID: 38641024
[TBL] [Abstract][Full Text] [Related]
40. Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.
Wu M; Li J; Yue L; Bai L; Li Y; Chen J; Zhang X; Yuan Z
Antiviral Res; 2018 Apr; 152():45-52. PubMed ID: 29432776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
